Pamicell, Top Search Ranking... Stock Price -7.13%
Pamisell has ranked among the top searched stocks for 10 days within the past month.
As of 9:30 AM on the 16th, Pamisell is trading at 22,150 KRW, down 7.13% from the previous day. This represents a 20.38% increase compared to June 25. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Over the past five days, individual investors have net purchased 516,090 shares, while foreigners and institutions have net sold 430,169 shares and net purchased 91,304 shares, respectively.
On July 15, Pamisell became a market topic with the announcement, "Holding 80% of the global nucleoside market... Moderna vaccine antibody formation."
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
